Page 1 If you can't read correctly this email, please click here ...
Page 1 If you can't read correctly this email, please click here ...
Page 1 If you can't read correctly this email, please click here ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<strong>If</strong> <strong>you</strong> can’t <strong>read</strong> <strong>correctly</strong> <strong>this</strong> <strong>email</strong>, <strong>please</strong> <strong>click</strong> <strong>here</strong><br />
mondoBIOTECH holding AG: the extraordinary shareholders'<br />
meeting approves all of the Board of Directors’ proposals<br />
Stans, 15 January 2010. The shareholders of mondoBIOTECH holding AG have<br />
unanimously approved two amendments to the Company's articles of<br />
incorporation at today's extraordinary shareholders' meeting, one relating to<br />
the usage of conditional share capital, and the other required due to the entry<br />
into force of the new Intermediated Security Act.<br />
Usage of conditional share capital<br />
The shareholders' meeting has approved the amendment to the articles of<br />
incorporation regarding the usage of the Company's existing conditional<br />
share capital. The amended art. 3b para. 2 of the articles of incorporation<br />
now creates the possibility to grant option rights to existing and/or new<br />
shareholders in connection with future capital increases which shall be<br />
covered by the Company's al<strong>read</strong>y existing conditional share capital. This<br />
amendment provides the Board of Directors with more flexibility in the<br />
procurement of capital. The first issuance of option rights pursuant to the<br />
amendment approved today is expected to be conducted in conjunction with<br />
the rights offering planned for the end of January 2010 (see also press<br />
release of yesterday, 14 January 2010).<br />
Form of the shares<br />
The shareholders' meeting approved a second amendment to the articles of<br />
incorporation. Art. 4 of the articles of incorporation relating to the form of<br />
the shares has been amended to comply with the new Swiss Intermediated<br />
Security Act which entered into force on 1 January 2010.<br />
"We thank all our shareholders for their confidence in the Board of Directors<br />
and in the Company" said Fabio Cavalli, CEO and member of the Board of<br />
Directors of mondoBIOTECH holding AG.<br />
About Mondobiotech<br />
Mondobiotech (mondoBIOTECH holding AG: SIX: RARE/ISIN:CH0101910732),<br />
an independent, internet-based biotech research company, discovers drugs<br />
for patients suffering from rare and neglected diseases. Mondobiotech has<br />
built a continuously growing global community of biologists, biochemists,<br />
physicians, patients and patient advocacy organizations who share their<br />
<br />
<br />
<br />
<strong>Page</strong> 1 of 3<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
passion and skills with Mondobiotech. Together with Mondobiotech, <strong>this</strong><br />
community is searching for treatments for rare and neglected diseases.<br />
For further information <strong>please</strong> contact:<br />
Dr. Yvonne Gunsch-Wegmann, MBA<br />
Head of External Relations<br />
mondoBIOTECH holding AG<br />
Das Kloster<br />
Mürgstrasse 18<br />
CH-6370 - Stans - Switzerland<br />
T +41 (0)840 200 010<br />
F +41 (0)41 611 09 34<br />
M +41 (0)79 414 39 33<br />
investor@mondobiotech.com<br />
www.mondobiotech.com<br />
Disclaimer<br />
The foregoing release may contain forward-looking statements.<br />
The words “anticipates”, “believes”, “estimates”, “expects”, “intends”,<br />
“may”, “plans”, “projects”, “will”, “would” and similar expressions<br />
are intended to identify forward-looking statements, although not all<br />
forward-looking statements contain these identifying words. mondoBIOTECH<br />
holding AG may not achieve the plans, intentions or expectations disclosed<br />
in its forward-looking statements and prospective investors should not<br />
place reliance on mondoBIOTECH holding AG’s forward looking statements.<br />
T<strong>here</strong> can be no assurance that results of the activities and results of<br />
operations will not differ materially from the expectations. Forward-looking<br />
statements are subject to in<strong>here</strong>nt risks and uncertainties, some of which<br />
cannot be predicted or quantified. Future events and actual results could<br />
differ materially from those set forth in, contemplated by or underlying the<br />
forward looking statements. mondoBIOTECH holding AG is providing the<br />
information in <strong>this</strong> press release as of <strong>this</strong> date and does not undertake any<br />
obligation to update any forward-looking statements contained in <strong>this</strong> press<br />
release as a result of new information, future events or otherwise.<br />
Personal Information<br />
This <strong>email</strong> is from mondoBIOTECH holding AG. The <strong>email</strong> and any files<br />
transmitted with it are intended solely for the use of the individual or entity to<br />
<br />
<br />
<strong>Page</strong> 2 of 3<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
which they are addressed. Any unauthorized dissemination or copying of <strong>this</strong><br />
<strong>email</strong> or its attachments, is strictly prohibited and may be illegal. <strong>If</strong> <strong>you</strong> have<br />
received the <strong>email</strong> in error <strong>please</strong> delete it from <strong>you</strong>r system.<br />
<br />
<br />
<strong>Page</strong> 3 of 3<br />
Change language